TMEM219 and glioma: Nevertheless, the lower expression of the TMEM219 gene was associated with survival in kidney renal clear cell carcinoma (FDR = 2.14∙10−3 (HR = 1.85)), glioma (FDR = 1.27∙10−2 (HR = 1.56)), lymphoid neoplasm diffuse large B-cell lymphoma (FDR = 4.110.54)), head and neck squamous cell carcinoma (FDR = 4.17E-2 (HR = 1.43)) and pan-kidney cohort (KICH+KIRC+KIRP) (FDR = 2.76E-1 (HR = 1.2)) (Figure 7A–C).